Active sites in Switzerland: Geneva-HUG, Bern-HUB, Lugano-Cardiocentro-Ticino, Zurich-HUZ
Start : january 2015
End : september 2021
Property: Université de Zurich, Swiss National Science Foundation, Novartis Pharmaceuticals
Zurich University, Swiss National Science Foundation, Novartis Pharmaceuticals Study on the short-term efficacy (5 days) of everolimus (Votubia on the Swiss market) on the size of the infarction, the scarring of the left ventricle and the inflammation compared to placebo in patients hospitalized with a myocardial infarction.